Heat Biologics Inc. said it regained compliance with Nasdaq Stock Market's minimum bid price requirement of $1 per share.
The Durham, N.C.-based company implemented a 1-for-10 reverse stock split of its common shares to regain compliance with Nasdaq's listing rule.
